The provided text appears to be a mix of technical scientific terms, references, and some nonsensical or garbled phrases. Below is an attempt to translate the coherent parts into English while maintaining their context:
---
**Rhein - Estrogen Conjugates Synthesis and Pharmacological Activity**, relation resulted proteins to bone by bisphosphonate conjugation. *Journal of Biotechnology Progress*, 2002, (3): 604-611. Tsusashi N, Yabuki M, Harada H, et al. Tissue distribution and pharmacological potential of SM16869, a novel estrogen-like bisphosphonate hybrid compound. *Journal of Pharmaceutical Pharmacology*, 2000, 52(1): 27-37.
Zheng H, Weng LL. Bone-resorption inhibition/osteogenesis promotion pharmaceutical composition: US Patent, 6028207. 2000-02-22.
Yokogawa K, Miya K, Sekido T, et al. Selective delivery of estradiol to bone by aspartic oligopeptide and its effects on ovariectomized mice. *DD Butterfly*, 2001, 142(3): 1128-1133.
Sekido T, Sakura N, VAS, IY, et al. Novel drug delivery system to bone using acidic oligopeptides: pharmacokinetic characteristics and pharmacological potential. *Journal of Targeting*, 2001, 9(2): 111-121.
Zhang Ping (Zhang P), Xu Jun (Xu J), Pang Shuzhen (Pang SZ), et al. Rhubarb anthraquinone derivatives on osteoclastic bone resorption function. *Journal of Beijing Medical University*, 1998, (Supplement): 25-29.
Li Lingzhi (uLZ), Song Yan (Song Y). In 3-a phenolic hydroxyl group phase transfer catalyzed etherification. *Journal of China Medicine University*, 1999, 30(4): 319-320.
Li Lingzhi (uLZ), Zheng Hu (Zheng H), Weng Lingling (Weng LL). Bone-targeted estrogen synthesis intermediates: piperazine derivatives. *Armed Police Journal of Medical Sciences*, 1999, 8(1): 10-17.
Liu Kai Tai (Liu KT), Ma Liying (Ma LY), Li Lingzhi (uLZ), et al. Bone organ culture in vitro methodology. *Journal of Xinjiang Medical University*, 2001, 24(1): 8-10.
---
**Chinese Pharmaceutical Yearbook**: A comprehensive chronicle of the development overview and significant achievements in our pharmaceutical field. Approved by the Ministry of Health in 1982, it was founded by China Medicine University, with Peng Sixun, an academician of the Chinese Academy of Engineering, serving as the chief editor. The yearbook covers various aspects of the pharmaceutical field, including pharmaceutical research, new drug development, pharmaceutical education, production and circulation, hospital pharmacy, drug regulation, personalities, publications, society and academic activities, and memorable events.
Published for over 20 years, the book is highly regarded for its dense information and detailed statistical data, making it an indispensable reference for pharmaceutical enterprises and institutions, as well as a valuable resource for medical workers.
The 2006 volume of the *Chinese Pharmaceutical Yearbook* was published in December 2006, consisting of 121 books, large 16 hardback, and available both domestically and internationally. Price: 232 yuan per copy. Full-text searching is available, and subscriptions are welcome.
Subscription Address: Editorial Department of the *Chinese Pharmaceutical Yearbook*, No. 24 Tong Lane, Nanjing City, China Medicine University. Postal Code: 210009. Telephone: 25.83271478, Fax: 25.
---
Note: Some parts of the original text were unclear or nonsensical (e.g., "ralph lauren skjorter," "Abercrombie Deutschland"), so they were omitted or interpreted based on context. If additional clarification is needed, please provide more details.